Prognostic effect of factors involved in revised Tokuhashi score system for patients with spinal metastases: a systematic review and Meta-analysis

• Published in: BMC cancer Vol. 18; no. 1; pp. 1248 - 15
• Main Authors: Yang, Xiong-gang, Lun, Deng-xing, Hu, Yong-cheng, Liu, Yong-heng, Wang, Feng, Feng, Jiang-tao, Hua, Kun-chi, Yang, Li, Zhang, Hao, Xu, Ming-you, Zhang, Hao-ran
• Format: Journal Article
• Language: English
• Published: London BioMed Central 13.12.2018; BioMed Central Ltd; BMC
• Subjects: Accuracy; Biomedical and Life Sciences; Biomedicine; Bones; Breast cancer; Cancer metastasis; Cancer patients; Cancer Research; Care and treatment; Health aspects; Health Promotion and Disease Prevention; Hepatocellular carcinoma; Liver cancer; Lung cancer; Lung carcinoma; Medical prognosis; Medicine/Public Health; Meta-analysis; Metastases; Metastasis; Non-small cell lung carcinoma; Oncology; Overall survival; Patients; Prognosis; Prognostic factor; Quality of life; Radiation therapy; Research Article; Revised Tokuhashi score; Small cell lung carcinoma; Spinal cord; Spinal metastasis; Spine; Studies; Supportive therapy; Surgery; Surgical Oncology; survivorship and psychosocial oncology; Systematic review; Thyroid cancer; Vertebrae; Prognostic factor; Spinal metastasis; Revised Tokuhashi score; Overall survival
• ISSN: 1471-2407; 1471-2407
• DOI: 10.1186/s12885-018-5139-2

Background Cancer patients’ survival time has obviously improved, with the development of systemic treatment techniques. However, the probability of metastases to the vertebrae has also been increased which makes some adverse effects on patients’ quality of life. The prediction of survival plays a key role in choosing therapeutic modality, and Tokuhashi Score was established as one of the most commonly used predictive systems for spinal metastases. Thus, this study was conducted to identify the prognostic effect of factors involved in revised Tokuhashi Score (RTS). Methods Two investigators independently retrieved relevant literature on platforms of PubMed, Embase and Cochrane Library. We identified eligible studies through title/abstract and full-text perusing. Data was extracted including general information of studies, participants’ characteristics, therapeutic modality, overall survival and prognostic effect of factors. Hazard ratio (HR) for each factor was synthesized if available through fixed- or random-effect models as appropriate. Results A total of 63 eligible studies with 10,411 participants were identified. Overall, cases with thyroid cancer had the highest survival rate, while the ones with non-small cell lung cancer and hepatocellular carcinoma lived for the shorted survival time. Performance status, bone metastasis, number of involved vertebrae, visceral metastasis, primary tumor and neurological status were regarded as significant predictors in 71.4, 40.0, 18.2, 63.4, 73.1 and 44.7% of the involved studies respectively. Thirty-eight articles were included in meta-analysis, and prognostic effects of five factors (apart from primary tumor) were analyzed. Factors were all proved to be significant except comparisons between KPS (Karnofsky Performance Status) 10–40 VS. 50–70 and single VS. multiple spinal metastases. Conclusion All factors of RTS were significant on prognosis predicting and should be considered when choosing therapeutic modality for spinal metastases. What’s more, we believe that more accurate prognosis may be obtained after removal of the cut-offs for KPS 10–40 VS. 50–70 and single VS. multiple involved vertebrae.